Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

Erstveröffentlichung

2023

Authors

de Botton, Stephane

Montesinos, Pau

Schuh, Andre C.

Papayannidis, Cristina

Vyas, Paresh

et al.

Wissenschaftlicher Artikel

Published in

Blood ; 141 (2023), 2. - S. 156-167. - ISSN 0006-4971. - eISSN 1528-0020

Link to publication

https://dx.doi.org/10.1182/blood.2021014901

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: INTERNATIONAL WORKING GROUP | RESPONSE CRITERIA | MUTATIONS | RECOMMENDATIONS | CLASSIFICATION | DIAGNOSIS | LEUKEMIA | IDH1
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record